Symmetry of Fv architecture is conducive to grafting a second antibody binding site in the Fv region

Biophysical Journal

Volumn 71, Issue 4, 1996, Pages 2002-2011

  Keck, Peter C ^a   Huston, James S ^a  

^a CURIS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DNA;

ANTIBODY COMBINING SITE; ARTICLE; CHIMERA; COMPUTER GRAPHICS; CRYSTAL STRUCTURE; GEOMETRY; MOLECULAR MODEL; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE; STRUCTURE ANALYSIS;

EID: 0029841188     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(96)79398-0     Document Type: Article

References (55)

1. Adair, J. R. 1992. Engineering antibodies for therapy. Immunol. Rev. 130:5-40.
2. Adams, G. P., J. E. McCartney, M.-S. Tai, H. Oppermann, J. S. Huston, W. F. Stafford III, M. A. Bookman, I. Fand, L. L. Houston, and L. M. Weiner. 1993. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv. Cancer Res. 53:4026-4034.
3. Amzel, L. M., and R. J. Poljak. 1979. Three-dimensional structure of immunoglobulins. Annu. Rev. Biochem. 48:961-997.
4. Bernstein, F. C., T. F. Koetzle, G. J. B. Williams, E. F. Meyer, M. D. Brice, J. R. Rodgers, O. Kennard, T. Shimanouchi, and M. J. Tasumi. 1977. The protein data bank: a computer-based archival file for macromolecular structures. J. Mol. Biol. 112:535-542.
5. Billetta, R., and M. Zanetti. 1993. Antigenicity and immunogenicity of antigenized antibodies. Studies on B and T cells. "Antibody Engineering. Medical Applications," ed. by M. Zanetti. Int. Rev. Immunol. 10:251-263.
6. Bird, R. E., K. D. Hardman, J. W. Jacobson, S. Johnson, B. M. Kaufman, S.-M. Lee, T. Lee, S. H. Pope, G. S. Riordan, and M. Whitlow. 1988. Single-chain antigen-binding proteins. Science. 242:423-426.
7. Blalock, J. E. 1994. Protein configurations. Science. 265:1511.
8. Borrebaeck, C., editor. 1995. Antibody Engineering, 2nd ed. Oxford University Press, New York and Oxford.
9. Brunet, A. P., E. S. Huang, M. E. Huffine, J. E. Loeb, R. J. Weltman, and M. H. Hecht. 1993. The role of turns in the structure of an α-helical protein. Nature. 364:355-358.
10. Clarke, B. L., and J. E. Blalock. 1990. Steroidogenic activity of a peptide specified by the reversed sequence of corticotropin mRNA. Proc. Natl. Acad. Sci. USA. 87:9708-9711.
11. Field, H., G. T. Yarranton, and A. R. Rees. 1988. Vaccines (Cold Spring Harbor). 88:29-34.
12. Field, H., G. T. Yarranton, and A. R. Rees. 1990. Expression of mouse light and heavy chain variable regions in Escherichia coli and reconstitution of antigen-binding activity. Protein Eng. 3:641-647.
13. Fischmann, T. O., G. A. Bentley, T. N. Bhat, G. Boulot, R. A. Mariuzza, S. E. V. Phillips, D. Tello, and R. J. Poljak. 1991. Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5 Å resolution. J. Biol. Chem. 266:12915-12920.
14. H domains. Proc. Natl. Acad. Sci. USA. 93:3675-3678.
15. George, A. J. T., F. Jamar, M.-S. Tai, B. T. Heelan, G. P. Adams, J. E. McCartney, L. L. Houston, L. M. Weiner, H. Oppermann, A. M. Peters, and J. S. Huston. 1995. Radiometal labeling of recombinant proteins by a genetically engineered, minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide. Proc. Natl. Acad. Sci. USA. 92:8358-8362.
16. George, A. J. T., J. A. Titus, C. R. Jost, I. Kurucz, P. Perez, S. M. Andrew, P. J. Nicholls, J. S. Huston, and D. M. Segal. 1994. Redirection of T cell-mediated cytotoxicity by a recombinant single-chain Fv molecule. J. Immunology. 152:1802-1811.
17. Greer, J. 1991. Comparative modeling of homologous proteins. Methods Enzymol. 202:239-252.
18. Hecht, M. H. 1994. De novo design of β-sheet proteins. Proc. Natl. Acad. Sci. USA. 91:8729-8730.
19. 2 dimers and chimeric bispecific antibody binding sites (χBABS). Fifth IBC International Conference on Antibody Engineering: New Technologies, Applications and Commercialization, La Jolla, CA, December 7-9.
20. Huston, J. S., and P. Keck. 1993. Chimeric multivalent protein analogues and methods of use thereof. Patent Cooperation Treaty WO 93/23537.
21. Huston, J. S., P. Keck, M.-S. Tai, D. Jin, J. McCartney, W. F. Stafford III, M. Mudgett-Hunter, H. Oppermann, and E. Haber. 1993a. Single-chain immunotechnology of Fv analogues and fusion proteins. In Immunotechnology, J. Gosling and D. Reen, editors. Portland Press, London. 47-60.
22. Huston, J. S., D. Levinson, M. Mudgett-Hunter, M.-S. Tai, J. Novotny, M. N. Margolies, R. J. Ridge, R. Bruccoleri, E. Haber, R. Crea, and H. Oppermann. 1988. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in E. coli. Proc. Natl. Acad. Sci. USA. 85:5879-5883.
23. Huston, J. S., M. N. Margolies, and E. Haber. 1996a. Antibody binding sites. Adv. Protein Chem. 49:327-447.
24. Huston, J. S., M. Mudgett-Hunter, M.-S. Tai, J. E. McCartney, F. D. Warren, E. Haber, and H. Oppermann. 1991. Protein engineering of single-chain Fv analogues and fusion proteins. Methods Enzymol. 203:46-88.
25. Huston, J. S., H. Oppermann, and S. N. Timasheff. 1996b. Serine-rich peptide linkers. U.S. Patent 5,525,491 (June 11, 1996).
26. Huston, J. S., M.-S. Tai, J. E. McCartney, P. Keck, and H. Oppermann. 1993b. Antigen recognition and targeted delivery by the single-chain Fv. Cell Biophys. 22:189-224.
27. Huston, J. S., M.-S. Tai, W. F. Stafford III, H. Oppermann, and P. Keck. 1994. Chimeric bispecific antibody binding sites (χBABS): 30 kD single-chain Fv proteins with dual binding sites. 11th International Hammersmith Meeting, Advances in the Applications of Monoclonal Antibodies in Clinical Oncology, Molyvos, Lesvos, Greece, May 23-26. 9.
28. Jeffrey, P. D., R. K. Strong, L. C. Sieker, C. Y. C. Chang, R. L. Campbell, G. A. Petsko, E. Haber, M. N. Margolies, and S. Sheriff. 1993. 26-10 Fab-digoxin complex: affinity and specificity due to surface complementarity. Proc. Natl. Acad. Sci. USA. 90:10310-10314.
29. Jones, P. T., P. H. Dear, J. Foote, M. S. Neuberger, and G. Winter. 1986. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature. 321:522-525.
30. Kabat, E. A., T. T. Wu, H. M. Perry, K. S. Gottesman, and C. Foeller. 1991. Sequences of Proteins of Immunological Interest, 5th ed. Publication No. 91-3242. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MD.
31. Kamtekar, S., and M. H. Hecht. 1995. The four-helix bundle: what determines a fold? FASEB J. 9:1013-1022.
32. Kamtekar, S., J. M. Schiffer, H. Xiong, J. M. Babik, and M. H. Hecht. 1993. Protein design by binary patterning of polar and nonpolar amino acids. Science. 262:1680-1685.
33. Keck, P. C., M.-S. Tai, H. Oppermann, and J. S. Huston. 1994. Chimeric bispecific antibody binding sites (χBABS): design of a second combining site within the Fv region and recovery of single-chain Fv binding activity after integration of new binding loops between β-strands of V domains. Biophys. J. 66:A431.
34. Knappik, A., and A. Plückthun. 1995. Engineered turns of a recombinant antibody improve its in vivo folding. Protein Eng. 8:81-89.
35. McCartney, J. E., M.-S. Tai, R. M. Hudziak, G. P. Adams, L. M. Weiner, D. Jin, W. F. Stafford III, S. Liu, M. A. Bookman, A. A. Laminet, I. Fand, L. L. Houston, H. Oppermann, and J. S. Huston. 1995. Engineering disulfide-linked single-chain Fv dimers [(sFv′)2] with improved solution and targeting properties. Anti-digoxin 26-10 (sFv′)2 and anti-c-erbB-2 741F8 (sFv′)2 made by protein folding and bonded through carboxyl-terminal cysteinyl peptides. Protein Eng. 8:301-314.
36. Neri, D., M. Momo, T. Prospero, and G. Winter. 1995. Hign-affinity antigen binding by chelating recombinant antibodies (CRAbs). J. Mol. Biol. 246:367-373.
37. Novotny, J., R. Bruccoleri, J. Newell, D. Murphy, E. Haber, and M. Karplus. 1983. Molecular anatomy of the antibody binding site. J. Biol. Chem. 258:14433-14437.
38. Novotny, J., R. E. Bruccoleri, and F. A. Saul. 1989. On the attribution of binding energy in antigen-antibody complexes McPC603, D1.3, and HyHEL-5 Biochemistry. 28:4735-4749.
39. L domain dimers. Proc. Natl. Acad. Sci. USA. 82:4592-4596.
40. Poljak, R. J., L. M. Amzel, H. P. Avey, B. L. Chen, R. P. Phizackerley, and F. Saul. 1973. Structure of Fab' NEW at 2.8 Å resolution. Proc. Natl. Acad. Sci. USA. 70:3305-3310.
41. Predki, P. F., V. Agrawal, A. T. Brünger, and L. Regan, 1996. Amino-acid substitutions in a surface turn modulate protein stability. Nature Struct. Biol. 3:54-58.
42. Quinn, T. P., N. B. Tweedy, R. W. Williams, J. S. Richardson, and D. C. Richardson. 1994. Betadoublet: de novo design, synthesis, and characterization of a β-sandwich protein. Proc. Natl. Acad. Sci. USA. 91:8747-8751.
43. Reichmann, L., J. Foote, and G. Winter. 1988. Expression of an antibody Fv fragment in myeloma cells. J. Mol. Biol. 203:825-828.
44. Sandlie, I., B. Bogen, and E. Lunde. 1996. Antigen presentation of a T cell epitope inserted at different positions in an antibody heavy chain. Keystone Symposium, Taos, NM, February 22-28. 47.
45. Satow, Y., G. Cohen, E. A. Padlan, and D. R. Davies. 1986. Phosphocholine binding immunoglobulin Fab McPC 603, an x-ray diffraction study at 2.7 Å. J. Mol. Biol. 190:593-604.
46. Searle, S. J., J. T. Pedersen, A. H. Henry, D. M. Webster, and A. R. Rees. 1995. Antibody structure and function. In Antibody Engineering, 2nd ed. C. Borrebaeck, editor. Oxford University Press, New York and Oxford. 3-51.
47. Segal, D. M., E. A. Padlan, G. H. Cohen, S. Rudikoff, M. Potter, and D. R. Davies. 1974. The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc. Natl. Acad. Sci. USA. 71:4298-4302.
48. H domain: implications for antibody engineering. Protein Eng. 5:229-234.
49. Skerra, A., and A. Plückthun. 1988. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science. 240:1038-1041.
50. Tai, M-S, J. E. McCartney, G. P. Adams, D. Jin, R. M. Hudziak, H. Oppermann, A. A. Laminet, M. A. Bookman, S. Liu, W. F. Stafford III, I. Fand, L. L. Houston, L. M. Weiner, and J. S. Huston. 1995. Targeting c-erbB-2 expressing tumors using single-chain Fv monomers and dimers. Cancer Res. 55(Suppl.):5983s-5989s.
51. Tai, M.-S., M. Mudgett-Hunter, D. Levinson, G.-M. Wu, E. Haber, H. Oppermann, and J. S. Huston. 1990. A bifunctional fusion protein containing Fc-binding fragment B of Staphylococcal protein A amino terminal to antidigoxin single-chain Fv. Biochemistry. 29:8024-8030.
52. Verhoeyen, M., C. Milstein, and G. Winter. 1988. Reshaping human antibodies: grafting an antilysozyme activity. Science. 239:1534-1536.
53. Winter, G., A. D. Griffiths, R. E. Hawkins, and H. R. Hoogenboom. 1994. Making antibodies by phage display technology. Annu. Rev. Immunol. 12:433-455.
54. Xiong, H., B. L. Buckwalter, H.-M. Shieh, and M. H. Hecht. 1995. Periodicity of polar and nonpolar amino acids is the major determinant of secondary structure in self-assembling oligomeric peptides. Proc. Natl. Acad. Sci. USA. 92:6349-6353.
55. Yan, Y., and B. W. Erickson. 1994. Engineering of betabellin 14D: disulfide-induced folding of a β-sheet protein. Protein Sci. 3:1069-1073.